Best Thymoma doctors in Turkey: TOP 25 doctors

Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood
Mustafa Solak
  • 4.5 Good 146 reviews
  • 19 years of experience
  • Turkey, Istanbul, Hisar Intercontinental Hospital
  • Mustafa Solak, M.D. is a medical doctor who graduated from Hacettepe University School of Medicine and has completed residencies at Istanbul Sisli Etfal Teaching and Research Hospital and a fellowship at Hacettepe University Cancer Institute. He specializes in Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, and Gastrointestinal Cancers. He has also worked at the University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.

  • Read more
Doctor's visit
Price on request
Elnur Sahibov
  • 4.2 Good 32 reviews
  • 9 years of experience
  • Turkey, Istanbul, Emsey Hospital
  • Licensed Radiation Oncologist with 8 years of medical training, including undergraduate studies at Marmara University Faculty of Medicine (2004-2011) and Radiation Oncology specialization training at Marmara University Faculty of Medicine (2012-2016). Previous education from Sixteen Numbered Shirvan School (Azerbaijan) High School (1998-2004).

  • Read more
Doctor's visit
Price on request
Dr Saban Secmeler
  • 4.4 Good 14 reviews
  • 13 years of experience
  • Turkey, Istanbul, Hermes Clinics
  • Dr. Saban Secmeler is a medical professional known for his contribution to cancer research, particularly a significant study on the impact of body mass index on the recurrence and survival rates in early-stage colorectal cancer.
  • Read more
Doctor's visit
Price on request
Evrim Metcalfe
  • 5 Excellent 2 reviews
  • 27 years of experience
  • Turkey, Istanbul, Medipol Bahçelievler Hospital
  • Experience

    2021 - 2022

    Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

    2021 - 2022

    Department of Radiation Oncology, Biruni University Faculty of Medicine

    2020 - 2021

    Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

    2017 - 2020

    Clinical Manager of Radiation Oncology, Neolife Medical Center

    2016 - 2017

    Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

    2011 - 2016

    Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

    2010 - 2011

    Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

    2008 - 2010

    Radiation Oncology Clinic, Samsun Training and Research Hospital (Education Coordinator)

    2006

    Medical Faculty, Dokuz Eylül University

    2006 - 2008

    Radiation Oncology Clinic, Samsun Mehmet Aydın State Hospital (Compulsory Service)

    2000 - 2006

    Medical Faculty, Dokuz Eylül University

     

    Education

    2022

    Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor

    2022

    Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism

    2021

    Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor

    2017

    Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Faculty Member

    2017

    Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor Doctor

    2006

    Samsun Training and Research Hospital, Specialist Doctor, Compulsory Service

    2006

    Dokuz Eylül University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization

    1998

    Ege University, Faculty of Medicine

     

     

  • Read more
Doctor's visit
Price on request
Mustafa Ondzhel
  • 4.5 Good 463 reviews
  • 23 years of experience
  • Turkey, Istanbul, Medipol Mega University Hospital
  • Professor of oncosurgery and proctology

  • Read more
Doctor's visit
Price on request
Nedret Taflan Salepci
  • 4.2 Good 5 reviews
  • 40 years of experience
  • Turkey, Istanbul, ISU Gaziosmanpasa
  • Dr. X is a Medical Oncologist with over 30 years of experience. He has a Medical Education from Istanbul University, specialization in Internal Medicine, and a Medical Oncology Specialization from Istanbul University's Oncology Institute. He is a member of the Medical Oncology Association, Lung Cancers Association, ESMO, ASCO and Istanbul Medical Chamber.

  • Read more
Doctor's visit
Price on request

Find out about the best doctors here

20 top ranked Thymoma doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.

The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.

Top 5 Thymoma doctors on Bookimed.com:

How to choose the best Thymoma doctors in the world?

The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.

Famous Thymoma doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.

What is the cost of a doctor's consultation?

The price for the consultation on Thymoma varies between experts and depends on certain factors, such as:

  • the country of practicing
  • the clinical experience and reputation
  • the medical degree and educational background
  • the doctor’s workload
  • medical developments, proprietary techniques used, and awards, if any.

How to make an appointment with a chosen doctor?

To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.

We can help to find the right doctors for Thymoma if you have any difficulties with a choice. Bookimed services are free for patients ♥

Where you go for medical treatment

Alper Can
  • 4.2 Good 5 reviews
  • 25 years of experience
  • accreditation:
  • Turkey, Istanbul, ISU Gaziosmanpasa
  • Medical Oncology specialist with expertise in lung, breast, colorectal, gastric, liver, kidney, pancreatic, stomach, prostate, and uterine cancers. Experienced in chemotherapy, immunotherapy, phytotherapy, ozone therapy, hyperthermic chemotherapy, GIS cancer, and gynecological and genitourinary cancer. Member of the Turkish Oncology Group, Medical Oncology Association, Turkish Cancer Research and Warfare Association, European Society of Medical Oncology, European Society of Gynecologic Oncology, and International Association for the Study of Lung Cancer.

  • Read more
Doctor's visit
Price on request
Mehmet Onur Ozturk
  • New
  • 15 years of experience
  • Turkey, İzmir, Bewell Health Assistance
Doctor's visit
Price on request
Mehmet Ozek
  • 4.1 Good 7 reviews
  • 44 years of experience
  • accreditation:
  • Turkey, Istanbul, Acibadem Altunizade Clinic
  • Dr. Aşkın Şeker is a highly respected Neurosurgeon with 23+ years of experience and numerous awards and achievements. He has interests in endoscopic skull base surgery, neuroanatomy, functional neurosurgery, movement disorders, spinal surgery, herniated disc, neck hernia and endoscopic surgeries. He is a member of numerous professional organizations and has 47 articles published in SCI international journals, papers presented in 33 international scientific meetings, 10 articles in national journals, and wrote chapters for 2 international books.

  • Read more
Doctor's visit
Price on request
Sezer Saglam
  • 5 Excellent 29 reviews
  • 28 years of experience
  • Turkey, Istanbul, Istanbul Florence Nightingale Hospital
  • Professional Experience

    Gayrettepe Florence Nigthingale Hospital

    Medical Oncology Department

    Besiktas/Istanbul/Turkey (ongoing)

     

    Education:

    He became Professor (22/April /2016)

    Medical Oncology

     

    Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

    Istanbul University Oncology Institue,

    Department of Medical Oncology

     

    Medical Oncology Fellowship (December 2001-December2004)

    Istanbul University, Istanbul Medical Faculty

     

    Hemodialysis Traning (May1996-January1997)

    Istanbul University ,bCerrahpasa Medical Faculty

     

    Internal Medicine Residency (November 1991-November 1996)

    Istanbul University ,bCerrahpasa Medical Faculty

     

    Ege University Medical Faculty (1985-1991)

     

    Professional Experience

     

    February 1999-November 2001

    Metropolitan Florence Nigthingale Hospital

    American Cancer Center, Gayrettepe/İstanbul

     

    April1997- October 1998

    Bayraktar Dialysis Center

    Güngören/ Istanbul

     

    Membership

     

    Turkish Medical Oncology Association

    ENET(European Neuroendocrine Tumour Society)

    ESMO

    ASCO

  • Read more
Doctor's visit
Price on request
Tahsin Ozadli
  • 4.7 Excellent 41 reviews
  • 22 years of experience
  • Turkey, Istanbul, Valued Med Hub Hospitals
  • Education and Expertise

    Selcuk University Meram Faculty of Medicine - Medical Education

    Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization

     

    Experience

    Malatya State Hospital Internal Diseases Clinic

    Ankara Oncology Hospital Medical Oncology Clinic

    Erzurum Regional Training and Research Hospital Medical Oncology Clinic


    AREAS OF INTEREST

    Lung cancer

    esophageal cancer

    Gastric cancer

    breast cancer

    Gastrointestinal surgery

    https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr 

  • Read more
Doctor's visit
Price on request
Muhammed Gomec
  • 5 Excellent 1 review
  • 16 years of experience
  • Turkey, Sivas, Medicana Sivas Hospital
Doctor's visit
Price on request
Nese Guney
  • New
  • 27 years of experience
  • Turkey, Istanbul, Biruni University Hospital
  • Dr. Nese Guney is a medical oncologist with 26 years of work experience, 9 of which are specifically in oncology. She is skilled in various procedures like mastectomy, thyroid resection, colon cancer removal, brachytherapy, proton-beam therapy, melanoma surgery, and others. Her research includes publications on topics related to lymphoma and ovarian metastasis.
  • Read more
Doctor's visit
Price on request
Hamza Ugur Bozbey
  • New
  • 11 years of experience
  • Turkey, Istanbul, Uniqacare Clinic
Doctor's visit
Price on request
Ilker Nihat Okten
  • 3.5 Good 3 reviews
  • 19 years of experience
  • Turkey, Istanbul, Istanbul Oncology Hospital
  • Dr. Ilker Nihat Okten is a medical oncologist who is board certified by the European Society of Medical Oncology (ESMO). He has been involved as a sub investigator in multiple phase III clinical trials for various cancers and has several publications in the field of oncology.
  • Read more
Doctor's visit
Price on request
Emrah Eraslan
  • New
  • 20 years of experience
  • Turkey, Ankara, Private Koru Ankara Hospital
  • Associate Professor Dr. Emrah Eraslan graduated from Ankara University Faculty of Medicine in 2005. From 2006 to 2011, he worked as a research assistant in the Department of Internal Medicine at Ankara University Faculty of Medicine and became an internal medicine specialist in 2011. Between 2011 and 2013, he worked as an internal medicine specialist and chief physician at Dr. Nafiz Körez Sincan State Hospital and Palu District State Hospital. From 2013 to 2016, he received medical oncology training at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital and worked there until 2021. In 2023, he became an associate professor and contributed to his field with his publications throughout his career. He currently serves his patients at Koru Ankara Hospital. His medical interests include:

    Breast Cancer

    Prostate Cancer

    Lung Cancer

    Colorectal Cancer

    Stomach Cancer

    Ovarian Cancer

  • Read more
Doctor's visit
Price on request
Seyda Gunduz
  • 4.3 Good 16 reviews
  • 15 years of experience
  • Turkey, Istanbul, Istinye University Liv Hospital Bahcesehir
Doctor's visit
Price on request
Alandag Celal
  • 5 Excellent 1 review
  • 16 years of experience
  • Turkey, Sivas, Medicana Sivas Hospital
Doctor's visit
Price on request
Abdullah Sakin
  • 5 Excellent 2 reviews
  • 18 years of experience
  • Turkey, Istanbul, Medipol Bahçelievler Hospital
  •  

    Experience

    2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

     

    2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

     

    2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

     

    2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

     

    2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

     

    2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

     

    2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

     

    2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

     

    2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

     

    2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

     

    2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

     

    2008 - 2012 Haseki Training and Research Hospital

     

    2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

     

     

    Education

    2018

    İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

    2018

    İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

    2012

    İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

    2012

    İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

    2007

    Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

     

  • Read more
Doctor's visit
Price on request
Nail Paksoy
  • 5 Excellent 2 reviews
  • 14 years of experience
  • accreditation:
  • Turkey, Istanbul, Medipol Bahçelievler Hospital

  • PROFESSIONAL EXPERIENCE

    2011-2012
    Erzurum Koprukoyu State Hospital
    Department: General Medicine

    2012-2017
    Istanbul University Cerrahpaşa Medical Faculty
    Department: Internal Medicine

    06/2017-10/2017
    Istanbul Gaziosmanpasa Taksim Training and Research Hospital
    Department: Internal Medicine

    10/2017-11/2018
    Istanbul University Istanbul Medical Faculty
    Department: Allergy and Immunology Fellowship

    2018/2022
    Istanbul University Oncology Institute
    Department: Medical Oncology Fellowship

    2022-2023
    Tekirdag City Hospital
    Department: Medical Oncology Specialist

    2023-present
    Istanbul Medipol University Medipol Bahcelievler Private Hospital
    Department: Medical Oncology Assoc. Prof.

     

    EDUCATION

    2005-2011
    Medical Education
    Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

    2012-2017
    Internal Medicine
    Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

    2017-2018
    Allergy-Immunology Fellowship
    Istanbul University Istanbul Medical Faculty
    Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

    2018-2022
    Medical Oncology Fellowship
    Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

    2022
    ESMO Board Certification in Medical Oncology
    10th September 2022 in Paris, France.

    2023
    Medical Oncology Assoc. Prof.
    Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

     

    INTERNATIONAL CLINICAL TRIALS:

    1. Astefania - ROCHE

    • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
    • Role: Subinvestigator

    2. PFİZER

    • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
    • Role: Subinvestigator

    3. RECITE - AMGEN

    • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
    • Role: Subinvestigator

    4. NAVIGATE - BAYER

    • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
    • Role: Subinvestigator

    5. RUBY - Tesaro (PRA)

    • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
    • Role: Subinvestigator

    6. ENGOT-ov43/GOG-3036 - MSD

    • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
    • Role: Subinvestigator

    7. ASTRA ZENECA

    • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
    • Role: Subinvestigator

    8. ROSY-O - ASTRA ZENECA

    • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
    • Role: Subinvestigator
    •  

    INTERNATIONAL PUBLICATIONS

    I. Published journal articles indexed by SCI, SSCI, and AHCI

    Weekly Paclitaxel in Classic Kaposi Sarcoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
    • Journal: Medicine, 102(5)

    Carboplatin Desensitization in Ovarian Carcinoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
    • Journal: Medicine, 101(45), e31726

    High-Dose Chemotherapy for Ewing’s Sarcoma

    • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
    • Journal: Medicine, 101(49), e32213

    Multidrug Refractory TFE3(+) Renal Cell Carcinoma

    • Authors: Paksoy, Nail, et al.
    • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

    Crizotinib Efficacy in NSCLC with MET Alterations

    • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
    • Journal: Medicine, 101(50), e32368

    Clinicopathological Features in ALK Mutant NSCLC

    • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
    • Journal: Medicine, 101(34)

    PSMA-Based Tumor Burden in Prostate Cancer

    • Authors: HAS SIMSEK, Duygu, et al.
    • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

    Atezolizumab in Metastatic Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: European Urology Focus, 2021, 7.5: 1061-1066

    Pulmonary Sarcomatoid Carcinoma

    • Authors: FERHATOGLU, Ferhat, et al.
    • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

    Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

    Atezolizumab with Chemotherapy in Small Cell Lung Cancer

    • Authors: GÜRBÜZ, Mustafa, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

    FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

    • Authors: AY, Seval, et al.
    • Journal: Journal of Chemotherapy, 2022, 1-7

    Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

    • Authors: CIL, Ibrahim, et al.
    • Journal: Tumori Journal, 2022, 108.1: 19-25

    Real-Life Efficacy of Osimertinib in Advanced NSCLC

    • Authors: HIZAL, Mutlu, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

    ALK-Positive Cells Percentage and Alectinib Efficacy

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
    • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

    Real-World Data on Alectinib in ALK-Positive NSCLC

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
    • Journal: Future Oncology, 18(23), 2573-2582

    Prognostic Factors in Metastatic RCC with T790M Mutation

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

    • Authors: DEMIR, Semra, et al.
    • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

    Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

    • Authors: ÖZDEMIR, Seçil Kepil, et al.
    • Journal: Allergy, 2019, 74.6: 1187-1190

    Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

    • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
    • Journal: The Oncologist, oyad257

    Subsequent Treatments in Hormone-Positive Breast Cancer Progression

    • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
    • Journal: BMC cancer, 23(1), 192

    Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
    • Journal: Scientific Reports, 13(1), 8779

    Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
    • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

    Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

    • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
    • Journal: European Journal of Breast Health, 19(2), 128

    Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

    • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
    • Journal: Future Oncology, 19(10), 727-736

    Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

    • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
    • Journal: [Not specified]

    Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

    • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
    • Journal: Medicine, 102(39), e35383

    Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

    • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
    • Journal: Medicine, 102(41), e35245

    Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

    Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

    Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

    Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

    Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

    Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

    Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

    Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

    Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

    Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

    Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

    Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

    Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

     

    Thesis:

    Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

    International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

    Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

    • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

    Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

    • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

    Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

    • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

    Efficacy of temozolomide in pretreated patients with metastatic sarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

    • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

    • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

    Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

    • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

    Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

    • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

    Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

    • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

     

     

  • Read more
Doctor's visit
Price on request
Choosing Right Doctor and Clinic: Insider Tips
When selecting a doctor or clinic, keep these key points in mind:
Check credentials
Verify certifications from bodies like ISAPS, JCI, etc.
Review success rates
Choose doctors with solid experience in your specific treatment.
Read patient reviews
Browse Bookimed reviews from real patients to learn about their experiences.
Ensure effective communication
Pick clinics that offer language support for a smooth treatment process.
Ask about services
Confirm if they provide accommodation and transfers, and check the costs.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team